Nantahala Capital Management’s Grace Therapeutics GRCE Stock Holding History

Nantahala Capital Management’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.37M	Sell	728,203 -450,000	-38%	-$1.77M	0.21%	113
2025 Q4	$4.08M	Hold	1,178,203	–	–	0.24%	108
2025 Q3	$3.51M	Hold	1,178,203	–	–	0.22%	117
2025 Q2	$3.5M	Hold	1,178,203	–	–	0.25%	105
2025 Q1	$2.69M	Buy	+1,178,203	New	+$3.71M	0.22%	101

Other funds holding GRCE

Cerity Partners

Cerity Partners New York $70.5B AUM 21.68% 1-Year Est. Return

Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return